医学
免疫抑制
协商一致会议
化学预防
淋巴增殖性病變
移植
重症监护医学
移植后淋巴增生性疾病
免疫学
外科
内科学
淋巴瘤
爱泼斯坦-巴尔病毒
病毒
作者
Michael Green,James E. Squires,Richard Chinnock,Patrizia Comoli,Lara Danziger‐Isakov,Daniel E. Dulek,Carlos O. Esquivel,Britta Höcker,Arnaud G. L’Huillier,George Mazariegos,Gary Visner,Catherine M. Bollard,Anne I. Dipchand,Judith A. Ferry,Thomas G. Gross,Robert J. Hayashi,Britta Maecker‐Kolhoff,Stephen D. Marks,Olivia M. Martinez,Diana Metes
摘要
Abstract The International Pediatric Transplant Association (IPTA) convened an expert consensus conference to assess current evidence and develop recommendations for various aspects of care relating to post‐transplant lymphoproliferative disorder after solid organ transplantation in children. In this report from the Prevention Working Group, we reviewed the existing literature regarding immunoprophylaxis and chemoprophylaxis, and pre‐emptive strategies. While the group made a strong recommendation for pre‐emptive reduction of immunosuppression at the time of EBV DNAemia (low to moderate evidence), no recommendations for use could be made for any prophylactic strategy or alternate pre‐emptive strategy, largely due to insufficient or conflicting evidence. Current gaps and future research priorities are highlighted.
科研通智能强力驱动
Strongly Powered by AbleSci AI